Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections

Sponsor
Womack Army Medical Center (U.S. Fed)
Overall Status
Terminated
CT.gov ID
NCT04163679
Collaborator
(none)
84
1
2
22.4
3.8

Study Details

Study Description

Brief Summary

asdgf

Condition or Disease Intervention/Treatment Phase
  • Procedure: Vaginal Preparation
N/A

Detailed Description

asdf

Study Design

Study Type:
Interventional
Actual Enrollment :
84 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Combining Vaginal Preparation and Azithromycin in Reduction of Post Cesarean Infections: A Randomized Controlled Trial
Actual Study Start Date :
Sep 18, 2019
Actual Primary Completion Date :
Jul 30, 2021
Actual Study Completion Date :
Jul 30, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Vaginal Preparation

In addition to standard care, subjects will undergo vaginal preparation (VP). A VP kit includes sponge sticks and sponges soaked in a povidone-iodine 10% solution.

Procedure: Vaginal Preparation
One sponge stick will be inserted into the vagina, where it will stay during the scrubbing of thighs and genitals. One sponge will be used to scrub the right inner thigh from mid-thigh to right labia majora. This sponge will then be discarded. A second sponge will be used to scrub the left inner thigh from mid-thigh to left labia majora. This sponge will then be discarded. A third sponge will be used to scrub the mons pubs, labia majora and minor, perineum and rectum in that order then will be discarded. This will be repeated with a fourth sponge. The existing sponge stick in the vagina will be rotated in the vagina twice then removed. This will be discarded. A second sponge stick will be inserted in the vagina, rotated twice then removed. As it is removed from the vagina, the perineum and rectum will be swabbed with the stick in that order then discarded. This will be repeated using a third sponge stick.

Sham Comparator: Standard Infection Procedures

The very staff will follow hospital protocols for the cesarean delivery. The subject and the infant will be provided care in accordance with current medical standards and be discharged at the discretion of the attending physician.

Procedure: Vaginal Preparation
One sponge stick will be inserted into the vagina, where it will stay during the scrubbing of thighs and genitals. One sponge will be used to scrub the right inner thigh from mid-thigh to right labia majora. This sponge will then be discarded. A second sponge will be used to scrub the left inner thigh from mid-thigh to left labia majora. This sponge will then be discarded. A third sponge will be used to scrub the mons pubs, labia majora and minor, perineum and rectum in that order then will be discarded. This will be repeated with a fourth sponge. The existing sponge stick in the vagina will be rotated in the vagina twice then removed. This will be discarded. A second sponge stick will be inserted in the vagina, rotated twice then removed. As it is removed from the vagina, the perineum and rectum will be swabbed with the stick in that order then discarded. This will be repeated using a third sponge stick.

Outcome Measures

Primary Outcome Measures

  1. Infection rates [Six weeks postpartum]

    wound infection

  2. Infection rates [six weeks postpartum]

    endometritis

Secondary Outcome Measures

  1. Infant Birth Weight [Four weeks after birth]

    record their birth weight (gm)

  2. Infant Apgar scores [Four weeks after birth]

    Apgar scores

  3. Infant Length of hospital stay [Four weeks after birth]

    Hospital stay (days)

  4. Numbers of Infants admitted to NICU [four weeks after birth]

    Infant admission to neonatal intensive care unit

  5. Number of Infants that develop respiratory distress [Four weeks after birth]

    The infant acquiring the condition of respiratory distress

  6. Number of Infants that develop sepsis [Four weeks after birth]

    Infant acquiring sepsis

  7. Number of infants that die [Four weeks after birth]

    Infant death

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • full term pregnancy

  • undergoing labored, non-emergent cesarean section

  • patient in labor

Exclusion Criteria:
Azithromycin contraindicated:
  • Known hypersensitivity to azithromycin, erythromycin, macrolides or ketolide medications.

  • liver dysfunction

  • Prescription medications which may interact with azithromycin, such as nelfinavir or warfarin

  • A history of a cardiac dysrhythmia (irregular heartbeats)

  • Known hypersensitivity to iodine

  • Patients carrying fetuses with known congenital anomalies

  • Immunodeficiency

  • Patients who are not in labor at the time of delivery

  • Non-english speaking subjects or subjects with language barriers

Contacts and Locations

Locations

Site City State Country Postal Code
1 Womack Army Medical Center Fort Bragg North Carolina United States 28310

Sponsors and Collaborators

  • Womack Army Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Karen L Wilson, Program Director of Obstetrics and Gynecology Residency Chief of Maternal Fetal Medicine and Obstetrics Chief, Womack Army Medical Center
ClinicalTrials.gov Identifier:
NCT04163679
Other Study ID Numbers:
  • RHC-A-19-033
First Posted:
Nov 15, 2019
Last Update Posted:
Oct 11, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 11, 2021